Analysis: Still wary of Russian vaccine, Brazil clears its own 'study' for more data

FILE PHOTO: Doses of the Sputnik V vaccine against the coronavirus disease (COVID-19) are seen at a vaccination centre in Zilina, Slovakia June 7, 2021. REUTERS/Radovan Stoklasa

BRASILIA (Reuters) - Russian vaccine developers cheered hard-won access to Brazil's market last week, but with less than a million doses cleared for import, public health experts say the approval is more like a late-stage trial for the Sputnik V shot.

Late Friday, Brazilian health regulator Anvisa, which was under pressure from state governors and the country's Supreme Court, ruled that states could import the Russian COVID-19 vaccine, but included some 20 strict conditions.